Dr. Vickers holds a Ph.D. in Biochemistry from the University of Toronto and a Bachelor of Science degree in Applied Biochemistry from the University of Salford, Manchester, England. Before joining Resolvyx, Dr. Vickers was Senior Vice President and Head of US Research for Boehringer-Ingelheim. Prior to Boehringer-Ingelheim, Dr. Vickers served as Vice President for Pfizer Global Research and Development and head of the Pfizer Research Technology Center in Cambridge, MA. He previously held various leadership positions within Pfizer's R&D organization including Executive Director of Genomic and Proteomic Sciences, and he served on the Pfizer Discovery Technology Board and the Pfizer Research Leadership Team. Dr. Vickers had previously worked at Merck Research Laboratories where his group conducted fundamental work on 5-lipoxygenase and cyclooxygenase-2 enzymes, resulting in the development of novel anti-inflammatory compounds.